Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

454.50
Delayed Data
As of Mar 27
 +6.13 / +1.37%
Today’s Change
269.50
Today|||52-Week Range
495.50
+10.79%
Year-to-Date

Today’s Trading

Previous close448.38
Today’s open449.48
Day’s range448.04 - 460.12
Volume856,036
Average volume (3 months)885,952
Market cap$46.6B
Dividend yield--
Data as of 03/27/2015

Growth & Valuation

Earnings growth (last year)-19.42%
Earnings growth (this year)+5.13%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+33.96%
P/E ratio148.1
Price/Sales14.64
Price/Book18.31

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+4.42+4.44%
QQuintiles Transnatio...+0.97+1.46%
ISISIsis Pharmaceuticals...+2.22+3.63%
ICLRICON PLC+0.85+1.22%
Data as of 03/27/2015

Financials

Next reporting dateApril 23, 2015
EPS forecast (this quarter)$2.67
Annual revenue (last year)$2.8B
Annual profit (last year)$348.1M
Net profit margin12.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account